FDA Psychopharmacologic Drugs Advisory Committee: Zyprexa
The Psychopharmacologic Drugs Advisory Committee will hold a public meeting to discuss new drug application (NDA) 22-173, ZYPREXA ADHERA (olanzapine…
Network with fellow health care journalists and gain valuable insights you can use every day.
Everyone should have access to quality health care information so they can make informed decisions. Join AHCJ today for exclusive access to training and education to inform your community.